Literature DB >> 21263092

Treatment of low-risk gestational trophoblastic neoplasia.

Carol Aghajanian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263092     DOI: 10.1200/JCO.2010.31.0151

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  10 in total

1.  Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Authors:  Caela R Miller; Nicole P Chappell; Caitlin Sledge; Charles A Leath; Neil T Phippen; Laura J Havrilesky; Jason C Barnett
Journal:  Gynecol Oncol       Date:  2016-11-03       Impact factor: 5.482

Review 2.  First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Authors:  Mo'iad Alazzam; John Tidy; Barry W Hancock; Raymond Osborne; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

3.  Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.

Authors:  J Qin; S Zhang; L Poon; Z Pan; J Luo; N Yu; L Wang; X Wu; X Cheng; X Xie; Y Lu; W Lu
Journal:  Ultrasound Obstet Gynecol       Date:  2021-05       Impact factor: 7.299

4.  Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009.

Authors:  A Sita-Lumsden; D Short; I Lindsay; N J Sebire; D Adjogatse; M J Seckl; P M Savage
Journal:  Br J Cancer       Date:  2012-10-11       Impact factor: 7.640

5.  Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia.

Authors:  R Agarwal; V Harding; D Short; R A Fisher; N J Sebire; R Harvey; D Patel; P M Savage; A K P Lim; M J Seckl
Journal:  Br J Cancer       Date:  2012-02-28       Impact factor: 7.640

6.  Gestational Choriocarcinoma Presenting with Lacrimal Gland Metastasis: A First Reported Case.

Authors:  Naushad A B Ahamed; Khalid Sait; Nisreen Anfnan; Khader Farwan; S H M Nizamuddin; Saleh S Baeesa
Journal:  Case Rep Obstet Gynecol       Date:  2015-05-20

7.  Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells.

Authors:  Lisha Xie; Tiancen Zhao; Jing Cai; You Su; Zehua Wang; Weihong Dong
Journal:  Onco Targets Ther       Date:  2016-11-17       Impact factor: 4.147

8.  The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy.

Authors:  Xiaodong Wu; Jiale Qin; Tao Shen; Weidong Fei; Lili Chen; Xing Xie; Weiguo Lu
Journal:  J Gynecol Oncol       Date:  2020-01-07       Impact factor: 4.401

Review 9.  First-line chemotherapy in low-risk gestational trophoblastic neoplasia.

Authors:  Theresa A Lawrie; Mo'iad Alazzam; John Tidy; Barry W Hancock; Raymond Osborne
Journal:  Cochrane Database Syst Rev       Date:  2016-06-09

10.  Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.

Authors:  Toshiyuki Kanno; Hideo Matsui; Yoshika Akizawa; Hirokazu Usui; Makio Shozu
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.